Paediatric Vaccinations


The ideal measure of efficacy, infection rates, is usually not studied as a primary endpoint because this requires large sample sizes. Surrogate measures such as immunogenicity are commonly used instead. Immunogenicity refers to the immune response induced by vaccination. Increased disease activity induced by vaccination and unintentional infections induced by live-attenuated pathogens in vaccines (especially in patients on high-dose immunosuppressive drugs). Another issue of vaccine safety is whether vaccines or their constituents can actually cause autoimmune disease (AID), which will be addressed briefly.



 


  • Two doses of measles mumps rubella at 9 and 15 months of age, and no standalone measles vaccine at 9 months.
  • Single dose administration of live attenuated H2 strain hepatitis A vaccine, or two doses of inactivated (killed) hepatitis A vaccine.

Related Conference of Paediatric Vaccinations

May 23-24, 2024

18th International Conference on European Immunology

Zurich, Switzerland
October 24-25, 2024

5th International Conference on Immunology And Immunotherapy

Zurich, Switzerland

Paediatric Vaccinations Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in